FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.654
EU - Europa 7.764
AS - Asia 5.770
SA - Sud America 888
Continente sconosciuto - Info sul continente non disponibili 304
AF - Africa 163
OC - Oceania 11
Totale 30.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.245
IT - Italia 2.201
GB - Regno Unito 2.048
SG - Singapore 1.735
CN - Cina 1.570
DE - Germania 892
VN - Vietnam 770
BR - Brasile 693
SE - Svezia 628
HK - Hong Kong 509
FR - Francia 440
RU - Federazione Russa 322
FI - Finlandia 263
UA - Ucraina 263
BD - Bangladesh 233
PL - Polonia 199
CA - Canada 192
TR - Turchia 188
KR - Corea 161
IN - India 160
BG - Bulgaria 93
NL - Olanda 85
JP - Giappone 69
AR - Argentina 64
MX - Messico 64
ID - Indonesia 62
IQ - Iraq 60
ZA - Sudafrica 52
BE - Belgio 46
ES - Italia 42
IE - Irlanda 41
AE - Emirati Arabi Uniti 35
CH - Svizzera 34
LT - Lituania 33
PK - Pakistan 32
AT - Austria 29
CL - Cile 24
HN - Honduras 24
CO - Colombia 23
CR - Costa Rica 23
EC - Ecuador 23
SA - Arabia Saudita 23
UZ - Uzbekistan 22
VE - Venezuela 20
JM - Giamaica 19
MA - Marocco 19
MY - Malesia 18
PH - Filippine 18
GT - Guatemala 16
PY - Paraguay 16
CZ - Repubblica Ceca 15
PT - Portogallo 15
DZ - Algeria 14
EG - Egitto 14
SV - El Salvador 14
AZ - Azerbaigian 13
JO - Giordania 12
DK - Danimarca 11
ET - Etiopia 11
IL - Israele 11
IR - Iran 11
KE - Kenya 11
PR - Porto Rico 11
SC - Seychelles 11
TT - Trinidad e Tobago 11
HU - Ungheria 10
PE - Perù 10
TN - Tunisia 10
BY - Bielorussia 9
NI - Nicaragua 9
BO - Bolivia 8
AU - Australia 7
BH - Bahrain 7
EU - Europa 7
GP - Guadalupe 7
AL - Albania 6
DO - Repubblica Dominicana 6
RO - Romania 6
SN - Senegal 6
TW - Taiwan 6
UY - Uruguay 6
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
KZ - Kazakistan 5
MD - Moldavia 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
LV - Lettonia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
TZ - Tanzania 4
EE - Estonia 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
Totale 30.220
Salva come PNG Salva come JPEG
Città #
Ashburn 1.874
Southend 1.466
Fairfield 1.296
Santa Clara 1.164
Singapore 1.058
Woodbridge 890
Chandler 753
San Jose 639
Houston 604
Seattle 532
Ann Arbor 512
Hong Kong 497
Jacksonville 470
Cambridge 469
Council Bluffs 458
Dearborn 458
Wilmington 445
Hefei 392
Frankfurt am Main 389
Nyköping 363
Beijing 291
Modena 277
London 242
Ho Chi Minh City 224
New York 212
Los Angeles 203
Hanoi 185
Helsinki 161
Chicago 155
Milan 148
Seoul 146
Kraków 145
The Dalles 123
Princeton 103
San Diego 93
Sofia 92
Izmir 91
Munich 89
Eugene 87
Shanghai 87
Moscow 85
Lauterbourg 82
Orem 77
Fremont 76
Rome 75
Buffalo 71
Redwood City 69
São Paulo 69
Boardman 60
Bologna 57
Dallas 54
Porto Alegre 54
Tokyo 52
Columbus 51
Bremen 46
Denver 45
Toronto 44
Brooklyn 43
Naples 43
Warsaw 43
Da Nang 42
Salt Lake City 41
Atlanta 40
Brussels 40
Dublin 40
Montreal 39
Des Moines 35
Phoenix 34
Guangzhou 32
Chennai 31
Jakarta 31
Verona 31
Grafing 30
Falls Church 28
Stockholm 28
Ottawa 27
Haiphong 26
Turku 26
Baghdad 25
San Francisco 25
Parma 24
Amsterdam 23
Belo Horizonte 23
Cape Town 23
Norwalk 22
Elk Grove Village 21
Tampa 20
Marseille 19
Mumbai 19
Paris 19
Poplar 19
Florence 18
Dhaka 17
Manchester 17
Mexico City 17
Miami 17
Milwaukee 17
Reggio Emilia 17
Saint Augustine 17
Turin 17
Totale 20.116
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 864
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 512
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 494
Metodo per la funzionalizzazione sito specifica di molecole proteiche 492
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 472
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 461
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 456
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 450
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 444
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 444
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 441
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 435
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 434
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 425
Antibacterial agent discovery using thymidylate synthase biolibrary screening 421
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 410
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 405
Biochemistry: Anchors away 400
Allosteric Inhibition of human Thymidylate Synthase. 400
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 397
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 397
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 394
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 391
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 389
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 383
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 380
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 373
A proteomic approach to investigate the mechanism of action of anticancer peptides 371
Crystal Structure of histidine-tagged human thymidylate synthase 370
Thymidylate synthase structure, function and implication in drug discovery 369
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 368
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 367
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 366
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 362
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 360
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 355
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 355
Biochemical effects of riluzole on Leishmania parasites 354
Current and Future Chemotherapy for Chagas Disease 354
ANTICANCER DRUGS 347
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 343
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 342
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 342
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 339
Homodimeric Enzymes as Drug Targets 336
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 336
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 336
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 332
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 330
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 329
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 327
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 326
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 325
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 317
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 316
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 315
Update on antifolate drugs targets 315
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 315
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 310
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 309
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 301
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 290
Target-based approaches for the discovery of new antimycobacterial drugs 290
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 286
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 275
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 275
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 273
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 272
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 265
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 265
Compounds having antiparasitic activity 263
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 261
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 255
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 253
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 249
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 243
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 237
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 236
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 229
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 220
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 219
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 218
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 217
Ovarian Cancer Drug Resistance 212
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 201
Medicinal chemistry in parasitology 199
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 194
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 191
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 173
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 147
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 143
Totale 30.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.518 0 0 0 0 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20267.959 456 309 563 906 1.222 557 1.036 388 834 794 455 439
2026/20272.351 208 551 615 734 243 0 0 0 0 0 0 0
Totale 30.554